XML 35 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
LOSS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2017
Earnings Per Share [Abstract]  
Schedule of Loss and Weighted Average Number of Shares
The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2017 and 2016 are as follows:
 
   
US dollars
   
US dollars
 
   
Six month period ended June 30,
   
Three month period ended June 30,
 
   
2017
   
2016
   
2017
   
2016
 
   
(unaudited)
   
(unaudited)
 
Loss for the period
   
(5,087,526
)
   
(2,815,762
)
   
(2,557,201
)
   
(1,588,998
)
Cash dividend on Series A Preferred Stock
   
(6,714
)
   
(9,453
)
   
(2,014
)
   
(4,753
)
Stock dividend on Series B Preferred Stock
   
(491,668
)
   
(254,101
)
   
(245,637
)
   
(131,281
)
Stock dividend on Series C Preferred Stock
   
(276,574
)
   
(20,355
)
   
(160,588
)
   
(20,355
)
Loss for the period attributable to common stockholders
   
(5,862,482
)
   
(3,099,671
)
   
(2,965,440
)
   
(1,745,387
)

   
Number of shares
   
Number of shares
 
   
Six month period ended June 30,
   
Three month period ended June 30,
 
   
2017
   
2016
   
2017
   
2016
 
Number of shares:
           
Common shares used in computing basic income (loss) per share
   
6,116,366
     
5,716,566
     
6,205,104
     
5,742,468
 
Common shares used in computing diluted income (loss) per share
   
6,116,366
     
5,716,566
     
6,203,104
     
5,742,468
 
Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)
   
19,868,112
     
11,220,345
     
21,001,400
     
12,210,613
 

(*)
All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive.